[Which factors determine the critical hematocrit as an indication for transfusion?].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1536435)

Published in Anaesthesist on January 01, 1992

Authors

W Dick1, C Baur, K Reiff

Author Affiliations

1: Klinik für Anästhesiologie, Johannes Gutenberg-Universität Mainz.

Articles by these authors

Quinolones and raised plasma concentrations of theophylline. Lancet (1984) 1.88

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch Toxicol (1997) 1.85

A non-contact mouse for surgeon-computer interaction. Technol Health Care (2004) 1.67

Transient post-renal obstruction may protect the kidney against nephrotoxic damage--a case report. Intensive Care Med (1995) 1.39

Pharmacokinetics and disposition of carvedilol in humans. J Cardiovasc Pharmacol (1987) 1.22

A navigation system for open liver surgery: design, workflow and first clinical applications. Int J Med Robot (2010) 1.18

Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. Eur J Clin Microbiol (1986) 1.16

Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis. Eur J Respir Dis Suppl (1986) 1.09

[Histamine release during induction of combination anesthesia using nalbuphine or fentanyl. Modulation of the reaction by premedication with promethazine/pethidine]. Anaesthesist (1992) 1.07

[New oral quinolone compounds in chronic bronchitis]. Infection (1986) 1.06

Lead in human bones. Investigations on an occupationally non-exposed population in southern Bavaria (F.R.G.). I. Adults. Sci Total Environ (1987) 1.04

The quinolones in chronic bronchitis. Pharm Weekbl Sci (1986) 1.02

Cefodizime in acute purulent exacerbations of chronic respiratory disease. J Antimicrob Chemother (1988) 0.95

Side-to-side differences in bone strength in master jumpers and sprinters. J Musculoskelet Neuronal Interact (2011) 0.89

Liver of the "visible man". Clin Anat (1997) 0.89

Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound. Eur J Clin Pharmacol (1990) 0.88

Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker. Eur J Clin Pharmacol (1987) 0.88

Seat belt use during pregnancy. West J Med (1992) 0.88

Enzymatic oxydation of linoleic acid: formation of bittertasting fatty acids. Z Lebensm Unters Forsch (1977) 0.87

Distribution and unspecific protein binding of the xenoestrogens bisphenol A and daidzein. Arch Toxicol (2002) 0.87

Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: novel mutations and concordance with the in vitro contracture test. Hum Mol Genet (1999) 0.87

Human skeletal muscle HSP70 response to physical training depends on exercise intensity. Int J Sports Med (2000) 0.86

Enzyme specific kinetics of 1,2-epoxybutene-3 in microsomes and cytosol from livers of mouse, rat, and man. Arch Toxicol (1991) 0.85

Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis. J Antimicrob Chemother (1987) 0.85

High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids. J Chromatogr (1987) 0.85

Robotic system for cervical spine surgery. Int J Med Robot (2011) 0.83

A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse, and human: formation of 2-hydroxyethyl adducts with hemoglobin and DNA. Toxicol Appl Pharmacol (2000) 0.83

Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease. J Antimicrob Chemother (1986) 0.82

Effect of 17beta-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17beta-estradiol serum kinetics and bone mass in rats. Calcif Tissue Int (1996) 0.82

Chordoma of the thorax. Eur J Respir Dis (1986) 0.82

Penetration of ofloxacin from blood to sputum. Drugs (1987) 0.81

Xenon does not trigger malignant hyperthermia in susceptible swine. Anesthesiology (1999) 0.79

A pharmacokinetic model to describe toxicokinetic interactions between 1,3-butadiene and styrene in rats: predictions for human exposure. IARC Sci Publ (1993) 0.77

Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats. Diabetes Res Clin Pract (1999) 0.77

Disposition of carvedilol enantiomers in patients with liver cirrhosis: evidence for disappearance of stereoselective first-pass extraction. J Cardiovasc Pharmacol (1992) 0.77

Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes. Br J Anaesth (1999) 0.77

A physiological toxicokinetic model for 1,3-butadiene in rodents and man: blood concentrations of 1,3-butadiene, its metabolically formed epoxides, and of haemoglobin adducts--relevance of glutathione depletion. Toxicology (1996) 0.76

HSP70 expression in skeletal muscle of patients with peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg (2002) 0.76

[DNA analysis of HLA class II and III genes in sudden infant death (SIDS)]. Beitr Gerichtl Med (1990) 0.76

[Species identification in traces using molecular biology methods]. Beitr Gerichtl Med (1989) 0.75

The use of quinolones in respiratory tract infections. Drugs (1987) 0.75

[Negligence of the physician's duty to care during "therapeutic local anesthesia"]. Dtsch Med Wochenschr (1991) 0.75

Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice. Arzneimittelforschung (1995) 0.75

[Histomorphology of the heart following resuscitation]. Beitr Gerichtl Med (1985) 0.75

[Regional distribution of predisposition to maligant hyperthermia in Germany: tate in 1997]. Anasthesiol Intensivmed Notfallmed Schmerzther (1998) 0.75

[Field study of drugs in criminal offenses]. Beitr Gerichtl Med (1979) 0.75

[Species identification by fragmented DNA]. Beitr Gerichtl Med (1989) 0.75

[Demonstrated value of ABO group determination of hair]. Beitr Gerichtl Med (1978) 0.75

[Investigation about the taste of di, tri- and tetrahydroxy fatty acid]. Z Lebensm Unters Forsch (1977) 0.75

[Comparative studies for the determination of female and male nuclear sex using hair]. Beitr Gerichtl Med (1982) 0.75

[Differentiation of food composition in the digestive tract]. Beitr Gerichtl Med (1989) 0.75

Pharmacokinetics of some new oral blood glucose-lowering agents in dogs. Arzneimittelforschung (1995) 0.75

[Comparative study between chemical fat content determination and the histological findings in the liver]. Beitr Gerichtl Med (1979) 0.75

[Interpretation of water content determinations of cadaver blood]. Beitr Gerichtl Med (1978) 0.75

[Type specificity of meat from the stomach contents of cadavers]. Beitr Gerichtl Med (1984) 0.75

[Derivation of the alcohol concentration in cardiac blood from its water content]. Beitr Gerichtl Med (1978) 0.75

[Frontal lobe changes in vagabonds]. Beitr Gerichtl Med (1986) 0.75

A B cell-suppressive IgG-antiimmunoglobulin antibody induced by alloimmunization. Transplantation (1990) 0.75

[Occupational medicine aspects of quinine production]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie (1983) 0.75

[Fatal traffic accidents and alcohol]. Beitr Gerichtl Med (1979) 0.75

An immunoglobulin-specific autoantibody occurring during alloimmunization suppresses the antibody response. Transpl Int (1992) 0.75

[Color reaction of p-cymol with vanillin-sulfuric acid]. Arch Pharm (Weinheim) (1977) 0.75

[The significance of nuclear Y-chromosome sex determination in forensic trace examination]. Beitr Gerichtl Med (1980) 0.75

Force feedback for virtual reality based minimally invasive surgery simulator. Stud Health Technol Inform (1996) 0.75

[The critical hematocrit--an analysis]. Klin Anasthesiol Intensivther (1993) 0.75

[Lipomatosis of the heart in chronic alcohol abuse]. Beitr Gerichtl Med (1985) 0.75

[Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)]. Arzneimittelforschung (1981) 0.75

[Determination of milk and cheese in stomach contents]. Beitr Gerichtl Med (1983) 0.75

[The clinical spectrum of urea cycle defects in adult patients]. Z Gastroenterol (2011) 0.75

[Conservative hemotherapy. Blood component therapy instead of whole blood transfusion and homologous blood saving methods]. Gynakologe (1995) 0.75

[Age determination of artificially produced hematomas]. Beitr Gerichtl Med (1981) 0.75

[Morphometry and quantitative lipid extraction in lipomatosis cordis]. Beitr Gerichtl Med (1987) 0.75

[Quantitative determination of lipids in the right heart muscle for verification of the diagnosis "lipomatosis cordis"]. Beitr Gerichtl Med (1982) 0.75

[Suicide through the utilization of postoperative conditions]. Arch Kriminol (1978) 0.75

[Do infusion solutions contain alcoholic cogeners? Determination of the content of volatile substances in 76 infusion solutions]. Blutalkohol (1985) 0.75

A haptic guidance tool for CT-directed percutaneous interventions. Conf Proc IEEE Eng Med Biol Soc (2004) 0.75

[Sudden death caused by an arterial hydatid embolism]. Dtsch Med Wochenschr (1997) 0.75

Studies on a new formulation of ceftazidime--ceftazidime arginine--in patients with recurrent chest infections. J Antimicrob Chemother (1987) 0.75

[Stomach contents and time of death]. Beitr Gerichtl Med (1980) 0.75

[Comparative studies of blood and body tissue for definite ABO determination in putrefaction]. Beitr Gerichtl Med (1983) 0.75